Zoetis (ZTS) Financial Analysis & Valuation | Quarter Chart
Zoetis (ZTS)
ZTSPrice: $79.57
Fair Value: 🔒
🔒score
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and compan... more
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines,... more
Description
Shares
| Market Cap | $33.36B | Exchange | NYSE |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | US | CEO | Kristin C. Peck |
| IPO Date | 2013-02-01 | CAGR | 0.08% |
| Employees | 13,800 | Website | www.zoetis.com |
| Div. Yield | 3.64% | Payout Ratio | 0.34% |
| Buy Back Yield | 14.36% | Total Yield | 18% |
ZTS chart loading...
Fundamentals
Technicals
| Enterprise Value | $56.46B | P/E Ratio | 13.04 |
| Forward P/E | 10.72 | PEG Ratio | 2.17 |
| P/S Ratio | 2.5 | P/B Ratio | 7.38 |
| P/CF Ratio | 8.78 | P/FCF Ratio | 11.09 |
| EPS | $6.1 | EPS Growth 1Y | 8.26% |
| EPS Growth 3Y | 36.12% | EPS Growth 5Y | 62.53% |
| Revenue Growth 1Y | 2.4% | Gross Margin | 0.71% |
| Operating Margin | 0.38% | Profit Margin | 0.28% |
| ROE | 0.62% | ROA | 0.17% |
| ROCE | 0.27% | Current Ratio | 3.15 |
| Quick Ratio | 1.91 | Cash Ratio | 0.94 |
| Debt/Equity | 2.86 | Interest Coverage | 14.83 |
| Altman Z Score | 4.74 | Piotroski Score | 7 |